Steve McGee does quality control on Advair devices at GlaxoSmithKline’s manufacturing facility in Zebulon on March 17, 2014.
Steve McGee does quality control on Advair devices at GlaxoSmithKline’s manufacturing facility in Zebulon on March 17, 2014. Chris Seward cseward@newsobserver.com
Steve McGee does quality control on Advair devices at GlaxoSmithKline’s manufacturing facility in Zebulon on March 17, 2014. Chris Seward cseward@newsobserver.com

GSK 2Q earnings boosted by post-Brexit decline of British pound

July 27, 2016 04:44 PM